Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
This is a narrative review synthesizing mechanistic evidence on platelet-tumor interactions without reporting primary experimental or clinical data, clinical endpoints, or quantified effect sizes.
This is a narrative review proposing a theoretical model of AIM's potential role in feline injection-site sarcoma, with no empirical data, experimental evidence, or clinical outcomes reported.
A narrative review summarizing the landscape of cellular therapies in sarcoma, reporting one FDA approval and describing early-stage investigational approaches without comparative efficacy data or quantified outcomes.
This is a narrative review proposing mechanistic connections between insulin resistance and cancer, with speculative discussion of monoclonal antibody therapeutics, but no primary experimental or clinical data to support efficacy claims.
Preclinical mechanistic study identifying neutrophils as key regulators of vaccine-induced antitumor immunity with potential therapeutic implications, but requires clinical validation.
This is a narrative review synthesizing existing knowledge on synthetic biology approaches to bacterial cancer immunotherapy, without reporting original experimental data, primary endpoints, or comparative efficacy claims.